000 01502 a2200433 4500
005 20250514051628.0
264 0 _c20021212
008 200212s 0 0 eng d
022 _a0009-9236
024 7 _a10.1067/mcp.2002.127739
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aSiegmund, Werner
245 0 0 _aThe effects of the human MDR1 genotype on the expression of duodenal P-glycoprotein and disposition of the probe drug talinolol.
_h[electronic resource]
260 _bClinical pharmacology and therapeutics
_cNov 2002
300 _a572-83 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aATP Binding Cassette Transporter, Subfamily B, Member 1
_xanalysis
650 0 4 _aAdult
650 0 4 _aArea Under Curve
650 0 4 _aDuodenum
_xchemistry
650 0 4 _aFemale
650 0 4 _aGenes, MDR
650 0 4 _aGenotype
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aPolymorphism, Genetic
650 0 4 _aPropanolamines
_xpharmacokinetics
650 0 4 _aRNA, Messenger
_xanalysis
700 1 _aLudwig, Karen
700 1 _aGiessmann, Thomas
700 1 _aDazert, Peter
700 1 _aSchroeder, Eike
700 1 _aSperker, Bernhard
700 1 _aWarzok, Rolf
700 1 _aKroemer, Heyo K
700 1 _aCascorbi, Ingolf
773 0 _tClinical pharmacology and therapeutics
_gvol. 72
_gno. 5
_gp. 572-83
856 4 0 _uhttps://doi.org/10.1067/mcp.2002.127739
_zAvailable from publisher's website
999 _c12233753
_d12233753